GREAT POINT PARTNERS LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:39 pm Purchase |
2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 11,473,166 9.990% |
1,950,734 (+20.49%) |
Filing |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 9,522,432 9.990% |
963,432 (+11.26%) |
Filing |
| 2024-07-18 4:10 pm Purchase |
2024-07-16 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 8,559,000 9.990% |
8,559,000 (New Position) |
Filing |